Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of Oral OTS167 in Healthy Adults
NCT02768519Phase 1Completed
- Sponsor
- OncoTherapy Science, Inc.
- Start
- Jan 2016
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in breast cancer, acute myeloid leukemia (AML) and solid tumor comparing OTS167 with Placebo (2 arms). Primary endpoints: Safety and Tolerability, Maximum Plasma Concentration and 3 more. Started Jan 2016; status: completed.
02
Drugs
OTS167
03
Conditions
breast canceracute myeloid leukemia (AML)solid tumor
Beyond the preview
Go deeper on NCT02768519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768519.